Clinical trials in cancer at Iowa barely lose a step

Last week, the American Society of Clinical Oncology (ASCO) released a special report titled “A Guide to Cancer Care Delivery During the COVID-19 Pandemic.” It details an approach for oncologists and other care providers to ensure their own safety and that of those they treat, given the higher likelihood of a patient’s immuno-compromised status.  For […]

Iowa results part of NEJM publication

A recent issue of the New England Journal of Medicine features the results of a multi-site clinical trial in which Dr. Mo Milhem and the University of Iowa’s Holden Comprehensive Cancer Center participated. Sorafenib, a kinase inhibitor primarily used to treat renal, hepatic, and thyroid carcinomas, was used against a placebo in a double-blind, phase […]

HOBMT Leadership Change

I am pleased to announce that we have implemented a new leadership structure for the Division of Hematology, Oncology, and Blood & Marrow Transplantation (HOBMT). The missions of the division have been divided operationally into a Section of Oncology led by Mohammed Milhem, MBBS, and a Section of Hematology led by Steven Lentz, MD, PhD. […]

Milhem Receives Humanism in Medicine Award

Mohammed Milhem, Clinical Professor in Hematology, Oncology, and Blood & Marrow Transplantation, has been awarded the Leonard Tow Humanism in Medicine Award from the Arnold P. Gold Foundation. Since 1991, this annual award has gone to a graduating student and a faculty member who demonstrate excellence and compassion in their patient care. The graduating Carver […]